Caliskan M, Tkel
HC, Benlidayi ME, Deniz A.
Is it necessary to alter anticoagulation therapy for tooth extraction in
patients taking direct oral anticoagulants? Med Oral Patol Oral Cir Bucal. 2017
Nov 1;22 (6):e767-73.
doi:10.4317/medoral.21942
http://dx.doi.org/doi:10.4317/medoral.21942
1.
Bauer KA. Pros and cons of new oral anticoagulants. Hematology Am Soc Hematol Educ
Program. 2013;2013:464-70. |
|
|
|
2. Ansell J, Hirsh J, Hylek E, Jacobson A, Crowther
M, Palareti G, et al. Pharmacology
and management of the vitamin K antagonists: American
College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008 Jun;133(6 Suppl):160S-98S. |
|
|
|
3. Firriolo FJ, Hupp WS. Beyond warfarin: the new generation of oral anticoagulants and their implications for the management of dental patients. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;113:431-41. |
|
|
|
4.
Barnes GD, Ageno W, Ansell
J, Kaatz S, Subcommittee on the Control of Anticoagulation of the
International Society on
T, Haemostasis. Recommendation
on the nomenclature for oral anticoagulants: communication from the SSC of the ISTH. J Thromb Haemost. 2015;13:1154-6. |
|
|
|
5. Perzborn E, Roehrig S, Straub A, Kubitza D, Misselwitz F. The discovery and development of rivaroxaban, an oral, direct factor Xa inhibitor. Nat Rev Drug Discov.
2011;10:61-75. |
|
|
|
6. Agnelli G, Buller HR, Cohen A,
Curto M, Gallus AS, Johnson M, et al. Apixaban for extended treatment of venous thromboembolism. N Engl J Med. 2013;368:699-708. |
|
|
|
7. Cheng JW, Vu H. Dabigatran etexilate: an oral direct thrombin inhibitor for the management
of thromboembolic disorders.
Clin Ther.
2012;34:766-87. |
|
|
|
8. Bacci C, Maglione M, Favero L, Perini A, Di Lenarda R, Berengo M, et al. Management of dental extraction in patients undergoing anticoagulant treatment. Results from a large, multicentre, prospective,
case-control study. Thromb
Haemost. 2010;104:972-5. |
|
|
|
9. Wahl MJ, Pinto A, Kilham J, Lalla RV. Dental surgery in anticoagulated patients--stop the interruption. Oral Surg Oral Med Oral Pathol Oral Radiol.
2015;119:136-57. |
|
|
|
10. Karsli ED, Erdogan O, Esen E, Acarturk E. Comparison of the effects of warfarin and heparin on bleeding
caused by dental extraction: a clinical study. J Oral Maxillofac Surg. 2011;69:2500-7. |
|
|
|
11. Salam S, Yusuf H, Milosevic A. Bleeding after dental extractions in patients taking warfarin. Br J Oral Maxillofac Surg. 2007;45:463-6. |
|
|
|
12.
Sacco R, Sacco M, Carpenedo M, Mannucci
PM. Oral surgery in patients
on oral anticoagulant therapy: a randomized comparison of different intensity targets. Oral Surgery
Oral Medicine Oral Pathology Oral Radiology and Endodontology.
2007;104:E18-E21. |
|
|
|
13.
Evans IL, Sayers MS, Gibbons
AJ, Price G, Snooks H, Sugar
AW. Can warfarin be continued
during dental extraction?
Results of a randomized controlled trial. Br J Oral Maxillofac
Surg. 2002;40:248-52. |
|
|
|
14. Devani P, Lavery KM, Howell CJ. Dental extractions
in patients on warfarin: is alteration of anticoagulant regime necessary? Br J Oral Maxillofac Surg.
1998;36:107-11. |
|
|
|
15. Mauprivez C, Khonsari RH, Razouk O, Goudot P, Lesclous P, Descroix V.
Management of dental extraction in patients undergoing anticoagulant oral direct treatment: a pilot study. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016;122:e146-e55. |
|
|
|
16.
Johnston S. An evidence summary of the management of patients taking direct oral anticoagulants (DOACs) undergoing dental surgery. Int J Oral Maxillofac Surg. 2016;45:618-30. |
|
|
|
17. Morimoto Y, Yokoe C, Imai Y, Sugihara M, Futatsuki T. Tooth extraction in patients taking nonvitamin K antagonist oral anticoagulants.
Journal of Dental Sciences.
2016;11:59-64. |
|
|
|
18. Hanken H, Grobe A, Heiland M, Smeets R, Kluwe L, Wikner J, et al. Postoperative bleeding risk for oral surgery under continued rivaroxaban anticoagulant therapy. Clin Oral Invest.
2016;20:1279-82. |
|
|
|
19. Abdullah WA, Khalil H. Dental extraction in patients on warfarin treatment.
Clin Cosmet Investig Dent. 2014;6:65-9. |
|
|
|
20. O'Connell JE, Stassen LF. New
oral anticoagulants and their
implications for dental patients. J Ir Dent Assoc. 2014;60:137-43. |
|
|
|
21. Munoz-Corcuera M, Ramirez-Martinez-Acitores
L, Lopez-Pintor RM, Casanas-Gil
E, Hernandez-Vallejo G. Dabigatran:
A new oral anticoagulant. Guidelines
to follow in oral surgery procedures. A systematic review of the literature. Med Oral Patol Oral Cir Bucal.
2016;21:e679-e88. |
|
|
|
22.
Curto A, Albaladejo A, Alvarado A. Dental management of patients taking novel oral anticoagulants
(NOAs): Dabigatran. J Clin Exp Dent.
2017;9:e289-e93. |
|
|
|
23.
Curto A, Albaladejo A. Implications
of apixaban for dental treatments. J Clin Exp Dent. 2016;8:e611-e4. |
|
|
|
24. Beyer-Westendorf J, Ebertz F, Forster K, Gelbricht V, Michalski F, Kohler C, et al. Effectiveness and safety of dabigatran
therapy in daily-care patients with atrial fibrillation. Results from the Dresden
NOAC Registry. Thromb Haemost. 2015;113:1247-57. |
|
|
|
25. Breik O, Cheng A, Sambrook PJ, Goss AN. Protocol in managing oral surgical patients taking dabigatran. Aust Dent J. 2014;59:296-301. |
|
|